Skip to content

Support for COVID19 Patients at Home

Targed Support for Patients Discharged After Hospitalization for SARS-CoV-2 Infection and Comorbidities. [ITALIAN. Supporto MIRATO ai Pazienti Dimessi Dopo un Ricovero Per Infezione da SARS-CoV-2 e comorbidità]

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04898179
Acronym
Mirato
Enrollment
796
Registered
2021-05-24
Start date
2020-11-01
Completion date
2022-01-16
Last updated
2024-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID19 Patients

Brief summary

The rapid spread and increase of acute respiratory infection cases caused by the novel SARS-CoV-2 coronavirus represent a major challenge for healthcare systems around the world. The shortage of facilities and medical personnel is a major problem in the face of a serious epidemic. The Lombardy Region, and in particular the territories of Milan, Bergamo and Brescia, was the most affected due to the rapid increase in cases and limited medical resources during the initial phase of the epidemic. The collaboration between hospital and territory with integrated communication systems and the monitoring of patients with appropriate technological tools that include telemedicine, are fundamental to ensure the continuity of care and the sustainability of the health system, also significantly reducing the risk of contagion for health professionals.

Detailed description

The MIRATO Project wants to test the remote health surveillance services and a telemonitoring program for patients discharged after a period of hospitalization for COVID19 caused by the new coronavirus SARS-CoV-2 and their comorbidities if present. Patients discharged from hospitals still present in many cases breathing difficulties, bed rest symptoms and other disabilities related to the acute event. In addition, some patients are seeing rekindling of symptoms such as fever, dry cough, difficulty respiratory and blood desaturation into oxygen. These problems underline the need for procedures that allow us to safely discharge patients to be able to better follow their convalescence but also to be able to intervene quickly in the event of symptoms returning. The purpose of the home health surveillance intervention will be: * Monitor the evolution of the state of health with standardized tools based on scientific evidence * Provide counselling support to help recovery * Have certain and early identification of signs and symptoms related to a possible resumption of the COVID19 pathology and or to comorbidities * Compare outcome results with case-control design three months after hospital discharge

Interventions

OTHERTelecare Group

Home-based telehealth program: telenursing and specialist teleconsultation Telemonitoring with a new pulse oximeter and specific App E-health platform Videoconference

OTHERControl group

Usual care

Sponsors

Istituto Auxologico Italiano
CollaboratorOTHER
Azienda Ospedaliera Bolognini di Seriate Bergamo
CollaboratorOTHER
Azienda Socio Sanitaria Territoriale di Bergamo
CollaboratorUNKNOWN
University of Bergamo
CollaboratorOTHER
Istituti Clinici Scientifici Maugeri SpA
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Hospitalisation for COVID19 * Patients discharged at home

Exclusion criteria

* Patient refusal * Patients discharged at a nursing home

Design outcomes

Primary

MeasureTime frameDescription
Number of Re-hospitalisation at three months3 monthsNumber of Re-hospitalisation registered at three months period in two groups
ER access at three months3 monthsNumber of ER accesses registered at three months period in two groups
Death at three months3 monthsNumber of death at three months in two groups

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026